Suchergebnisse - "2494G1JF75"

PubPharm (15)

1

Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands

enthalten in: Therapeutic drug monitoring | 2011

von van Luin, M. | Wit, F. | Smit, C. | +6

2

Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens

enthalten in: Therapeutic drug monitoring | 2008

von Baroncelli, S. | Villani, P. | Floridia, M. | +9

3

Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis

enthalten in: Therapeutic drug monitoring | 2008

von Micheli, V. | Regazzi, M. | Dickinson, L. | +11

4

Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring

enthalten in: Therapeutic drug monitoring | 2007

von Slish, J. | Ma, Q. | Zingman, B. | +9

5

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors : validation and application

enthalten in: Therapeutic drug monitoring | 2007

von Keil, K. | Hochreitter, J. | DiFrancesco, R. | +5

6

A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults

enthalten in: Therapeutic drug monitoring | 2006

von van der Leur, M. | Burger, D. | la Porte, C. | +1

7

Limited penetration of lopinavir and ritonavir in the genital tract of men infected with HIV-1 in Brazil

enthalten in: Therapeutic drug monitoring | 2006

von Vergara, T. | Estrela, R. | Suarez-Kurtz, G. | +3

8

Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients

enthalten in: Therapeutic drug monitoring | 2005

von Antoniou, T. | Tseng, A. | van Heeswijk, R. | +3

9

No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir : a population approach

enthalten in: Therapeutic drug monitoring | 2005

von Dailly, E. | Gagnieu, M. | Allavena, C. | +2

10

Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography

enthalten in: Therapeutic drug monitoring | 2005

von Poirier, J. | Robidou, P. | Jaillon, P.